Abstract
Background and Aims: Contemporary studies show that sST2 may be considered as a promising predictor of LV remodeling and adverse prognosis in patients with acute myocardial infarction (AMI). The aim of the study was to investigate the effect of sST2 on the development of LV remodeling in patients with STEMI and the efficacy of different doses of bisoprolol in reducing the incidence of adverse events.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
